Benefical effects of lycopene against contrast medium-induced oxidative stress, inflammation, autophagy, and apoptosis in rat kidney

Human and Experimental Toxicology

Volumn 34, Issue 5, 2015, Pages 487-496

  Buyuklu, M ^a   Kandemir, F M ^b   Ozkaraca, M ^b   Set, T ^b   Bakirci, E M ^a   Topal, E ^a   Ileriturk, M ^b   Turkmen, K ^a  

^a ERZINCAN UNIVERSITY   (Turkey)

^b ATATÜRK UNIVERSITY   (Turkey)

Author keywords

apoptosis; autophagy; Contrast nephropathy; inflammation; lycopene; oxidative stress

Indexed keywords

CASPASE 3; CATALASE; CREATININE; FUROSEMIDE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; INDOMETACIN; INDUCIBLE NITRIC OXIDE SYNTHASE; IOMEPROL; LC3 PROTEIN; LYCOPENE; MALONALDEHYDE; PEPTIDES AND PROTEINS; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; UREA; ANTIOXIDANT; CAROTENOID; CONTRAST MEDIUM; NOS2 PROTEIN, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIAPOPTOTIC ACTIVITY; ANTIAUTOPHAGIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEGENERATION; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEHYDRATION; DRUG ACTIVITY; DRUG EFFICACY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; INFLAMMATORY INFILTRATE; KIDNEY PARENCHYMA; MALE; NONHUMAN; OXIDATIVE STRESS; PREVENTION STUDY; PRIORITY JOURNAL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; METABOLISM; NEPHRITIS; PATHOLOGY; WISTAR RAT;

RATTUS;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; AUTOPHAGY; CAROTENOIDS; CONTRAST MEDIA; IMMUNOHISTOCHEMISTRY; KIDNEY; MALE; NEPHRITIS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; RATS, WISTAR;

EID: 84928179657     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327114542964     Document Type: Article

References (39)

1. Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 2004 ; 44: 12-24
2. Sanaei-Ardekani M, Movahe MR, Movafagh S, et al. Contrast-induced nephropathy: a review. Cardiovasc Revasc Med. 2005 ; 6: 82-88
3. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005 ; 68: 14-22
4. Wong PC, Li Z, Guo J, et al. Pathophysiology of contrast-induced nephropathy. Int J Cardiol. 2012 ; 158: 186-192
5. Romano G, Briguori C, Quintavalle C, et al. Contrast agents and renal cell apoptosis. Eur Heart J. 2008 ; 29: 2569-2576
6. Barrett BJ, Parfrey PS.. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006 ; 354: 379-386
7. Story EN, Kopec RE, Schwartz SJ, et al. An update on the health effects of tomato lycopene. Annu Rev Food Sci Technol. 2010 ; 1: 189-210
8. Palabiyik SS, Erkekoglu P, Zeybek ND, et al. Protective effect of lycopene against ochratoxin A induced renal oxidative stress and apoptosis in rats. Exp Toxicol Pathol. 2013 ; 65 (6). 853-861
9. Cohen LA. A review of animal model studies of tomato carotenoids, lycopene, and cancer chemoprevention. Exp Biol Med (Maywood). 2002 ; 227 (10). 864-868
10. Gazi S, Altun A, Erdogan O. Contrast-induced nephropathy: preventive and protective effects of melatonin. J Pineal Res. 2006 ; 41: 53-57
11. Aebi H. Catalase. In: Methods of enzymatic analysis. New York: Academic Press ; 1983: 276-286.
12. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951 ; 193: 265-275
13. Ellman G. Tissue sulphydryl groups. Arch Biochem Biophys. 1959 ; 82: 70-77
14. Beutler E. Red cell metabolism. In: Beutler E, ed. A manual of biochemical methods. NewYork: Grune Strottan ; 1975: 67-69.
15. Placer ZA, Cushmanni LL, Johnson BC. Estimation of products of lipid peroxidation (as malondialdehyde) in biochemical systems. Anal Biochem. 1966 ; 16: 359-364
16. Goering PL, Morgan DL, Ali SF. Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal. J Appl Toxicol. 2002 ; 22: 167-172
17. Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005 ; 172: 1461-1471
18. Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest Radiol. 2002 ; 37: 428-434
19. Tervahartiala P, Kivisaari L, Kivisaari R, et al. Structural changes in the renal proximal tubular cells induced by iodinated contrast media. Nephron. 1997 ; 76: 96-102
20. Kongkham S, Sriwong S, Tasanarong A. Protective effect of alpha tocopherol on contrast-induced nephropathy in rats. Nefrologia. 2013 ; 33: 116-123
21. Boyacioglu M, Turgut H, Akgullu C, et al. The efficient of L-carnitine on oxidative stress responses of experimental contrast-induced nephropathy in rat. J Vet Med Sci. 2014 ; 76: 1-8
22. ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized acetylcysteine for contrast-induced nephropathy trial (ACT). Circulation. 2011 ; 124: 1250-1259
23. Briguori C, Airoldi F, D'Andrea D, et al. Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation. 2007 ; 115: 1211-1217
24. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004 ; 110: 2837-2842
25. Ateşşahin A, Karahan I, Türk G, et al. Protective role of lycopene on cisplatin-induced changes in sperm characteristics, testicular damage and oxidative stress in rats. Reprod Toxicol. 2006 ; 21 (1). 42-47
26. Ari E, Kedrah AE, Alahdab Y, et al. Antioxidant and renoprotective effects of paricalcitol on experimental contrast-induced nephropathy model. Br J Radiol. 2012 ; 85: 1038-1043
27. Toprak O, Cirit M, Tanrisev M, et al. Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrol Dial Transplant. 2008 ; 23: 853-859
28. Efrati S, Dishy V, Averbukh M, et al. The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int. 2003 ; 64: 2182-2187
29. Sugimoto H, Shikata K, Wada J, et al. Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumour necrosis factoralpha and inducible nitric oxide synthase in diabetic rat glomeruli. Diabetologia. 1999 ; 42: 878-886
30. Trachtman H, Futterweit S, Pine E, et al. Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatr Nephrol. 2002 ; 17: 20-29
31. Manikandan R, Beulaja M, Thiagarajan R, et al. Ameliorative effects of curcumin against renal injuries mediated by inducible nitric oxide synthase and nuclear factor kappa B during gentamicin-induced toxicity in Wistar rats. Eur J Pharmacol. 2011 ; 30: 578-585
32. Su M, Mei Y, Sinha S. Role of the crosstalk between autophagy and apoptosis in cancer. J Oncol. 2013 ; 2013: 102735
33. White E, DiPaola RS. The double-edged sword of autophagy modulation in cancer. Clin Canc Res. 2009 ; 15: 5308-5316
34. Rubinsztein DC, Cuervo AM, Ravikumar B, et al. In search of an "autophagomometer". Autophagy. 2009 ; 5: 585-589
35. Funk JA, Schnellmann RG. Persistent disruption of mitochondrial homeo-stasis after acute kidney injury. Am J Physiol Renal Physiol. 2012 ; 302: 853-864
36. Kimura T, Takabatake Y, Takahashi A, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol. 2011 ; 22: 902-913
37. Domitrovic R, Cvijanovic O, Pernjak-pugel E, et al. Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis. Food Chem Toxicol. 2013 ; 62: 397-406
38. Servais H, Ortiz A, Devuyst O, et al. Renal cell apoptosis induced by nephrotoxic drugs: cellular and molecular mechanisms and potential approaches to modulation. Apoptosis. 2008 ; 13: 11-32
39. Yano T, Itoh Y, Sendo T, et al. Cyclic AMP reverses radiocontrast media-induced apoptosis in LLC-PK1 cells by activating A kinase/PI3 kinase. Kidney Int. 2003 ; 64: 2052-2063